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SUMMARY 
Oxidative stress has been implicated in the pathogenesis, progression of chronic kidney disease (CKD) and develop-
ment of cardiovascular complications. Hemodialysis (HD) has also been described to contribute significantly to oxi-
dative stress in CKD patients, though reports are conflicting. 
Objective: We evaluated the effects of one session of HD on the antioxidant capacity and lipid peroxidation in CKD 
patients. 
Method: Thirty-six CKD patients requiring HD were recruited into this study. Participants were naïve to HD and each 
completed a session of three hours using polysulfone membrane dialyzers. Blood samples were collected before and 
after dialysis. Total antioxidant capacity (TAC) was measured by ferric reducing antioxidant power (FRAP) while 
malondialdehyde (MDA) was measured using thiobarbituric acid-reactive substance (TBARS). Comparison was made 
between pre-HD and post-HD values of TAC and MDA respectively, p value of <0.05 was taken as significant. 
Result: Mean age and estimated glomerular filtration rate of subjects were 45 ±15 years and 6.3± 4.7mls/1.73m2 
respectively. There was significant decrease in the mean TAC from 1232.2 ± 495.6 µmol Trolox equiv/ to 832.4 ± 
325.7 µmol  Trolox equiv/L post-dialysis (p< 0.001) while MDA values were similar before and after HD (11.8 ± 1.8 
vs 11.8 ± 2.331)µmol/L (p> 0.05). There was no significant association between changes in antioxidant status follow-
ing HD with blood flow rate, ultrafiltration volume nor dialyzer per size. 
Conclusion: A session of HD in patients with CKD is associated with significant reduction of the total antioxidants 
capacity; and no effect on MDA levels. 
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INTRODUCTION 
Oxidative stress has been described to play an important 
role in disease progression and development of cardio-
vascular complications in chronic kidney disease (CKD) 
patients. CKD is characterized by an imbalance between 
pro-oxidant and anti-oxidant factors in favor of oxidants 
which predisposes them to increased risk of 
cardiovascular disease and increased mortality.1 
 
Though oxidative stress may be directly associated with 
renal insufficiency as observed in early stages of CKD, it 
is most pronounced in patients on dialysis.1 A number of 
mechanisms have been postulated as being responsible 
for oxidative stress in these subjects; certain studies 
suggested an alteration of the oxidative stress 
phenomenon, by production of reactive oxygen species 
on the surface of dialysis membranes and activation of 
polymorphonuclear leukocytes in patients undergoing 
hemodialysis (HD)2,3, another study suggested loss of an-
tioxidant during the course of HD through the dialyzer 
membranes4 ,while some studies claim uremia is gener-
ally associated with increased oxidative stress.5 
 
Haemodialysis, the commonest renal replacement 
therapy in developing countries, has been reported to 
induce repetitive bouts of oxidative stress primarily 
through membrane bio-incompatibility.6,7 While CKD is 
a pro-oxidant state, HD may contribute significantly to 
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Total antioxidant capacity is described as the sum total of 
all endogenous and exogenous antioxidant in a medium.8 
It consist of enzymes such as glutathione peroxidase, cat-
alase, superoxide dismutase as well as macromolecules 
such as cerulosplasmin, uric acid, ferritin and a number 
of micromolcules such as ascorbic acid, alpha tocopherol 
and beta carotene. Combination of these components pro-
vides a better protection against reactive species than in-
dividual antioxidant. 
 
Malondiadehyde (MDA) is an intermediate product of li-
pid peroxidation which serves as evidence of oxidation 
of lipids following HD. Elevated levels of MDA has been 
reported in CKD as evidence of free radical generation.9 
This study was designed to evaluate the effects of one 
session of HD using the standard polysulfone membrane 
on antioxidant status of newly-diagnosed hemodialysis- 
naive CKD patients who required HD. 
 
METHODS 
This study was conducted at the Kidney Care Centre, 
University of Medical Science, Ondo city between April 
2015 and March 2016. Ethical approval was obtained 
from the ethics and research committee, Kidney Care 
Centre Ondo (under the auspices of Ondo state Hospital 
Management Board Ondo State, Nigeria.) and all partic-
ipants gave written consent to participate in the study. In-
clusion criteria were newly diagnosed adult Stage 5 CKD 
patients who required HD and signed written consent to 
participate in the study. Exclusion criteria were those on 
antioxidant supplement and lipid lowering medications.   
5ml of venous blood collected just before dialysis (as pre 
dialysis sample) and 30 minutes after completion of the 
first session of HD (as post dialysis). Samples were sep-
arated and kept at -2oC till analysis. Glomerular filtration 
rate (GFR) was calculated using the MDRD formula 




Serum creatinine and urea were analyzed using standard 
spectrophotometric methods (using reagents commer-
cially prepared by RANDOX). 
 
Total antioxidant potential was analyzed using commer-
cially prepared reagent using the ferric reducing antioxi-
dant power (FRAP) assay method as described by Benzie 
and Strain.11 50uL of sample was reacted with 1.5 mL 
freshly constituted working reagent (2, 4, 6-tripyridyl-s- 
triazine and Ferric chloride hexahydrate) at 370C and re-
sult expressed in µmol Trolox equiv/L. MDA was meas-
ured using thiobarbituric acid-reactive substance 
(TBARS) as described by Varshnsey and Kale.12  
100uL of deproteinized sample was added to 1mL of 
TBARS reagents and incubated at 1000C for 20 min ex-
pressed in umol/L.  
 
Statistical analysis. 
Comparison between the mean values of TAC and MDA 
before and after HD was done using students’ t-test. 




A total of 36 CKD patients requiring HD participated in 
this study, 29 were males and 7 were females. The mean 
age was 45 ±15 years, systolic blood pressure, diastolic 
blood pressure, packed cell volume, serum urea, creati-
nine and estimated GFR before HD were 148.9 ± 
29.2mmHg, 86.4± 20.0mmHg, 21.8 ± 5.03%, 40.7 ± 19.1 
mmol/L, 1420 ± 856.0 µmol/L, 6.3 ± 4.7mL/min/1.73m2 
respectively. Ultrafiltration volume and blood flow rate 
of the study participants were 1.69 ± 1.59 L and 302 ± 
60.9ml/min respectively (Table 1). 
 
Aetiology of CKD among the study participants were hy-
pertension in 12(33.3%), chronic glomerulonephritis in 
11(30.6%), diabetes mellitus in 7(19.4%) and others in 6 
(16.7%) (Table 2). 
 
Table1 Characteristics of study population.  
Parameters Mean± SD / n(%) 
Age 45 ± 15 years 
Systolic blood pressure 148.9 ± 29.2 mmHg 
Diastolic blood pressure 86.4 ± 20.0 mmHg 
Packed cell volume 21.8 ± 5.03 % 
Serum urea 40.7 ± 19.1 mmol/L 
Serum creatinine 1420 ± 856.0 micromol/L 
Estimated GFR 6.3 ± 4.7 mL/min/1.73m2 
Ultrafiltration volume 1.69 ± 1.59 L 
Blood flow rate 302 ± 60.9 ml/min 
 
 
Table 2 Aetiology of CKD among the participants. 
Aetiology of CKD n(%) 
Hypertension 12 (32.4%), 
Chronic glomerulonephritis 11 (29.7%) 
Diabetes mellitus 7 (18.9) 
Others 6 (16.2%). 
 
There was significant decrease in the mean TAC from 
1232.2 ± 495.6 to 832.4 ± 325.7 µmol Trolox equiv/L 
(p<0.001) after a single session of HD. There was no sig-
nificant change in mean MDA values after a single HD 






                                                                                                                                                                               
www.ghanamedj.org  Volume 52 Number 1 March 2018 31 
Blood flow rate, ultrafiltration volume and blood pres-
sure did not significantly affect changes in MDA and 
TAC following HD (p>0.05) (Tables 4 and 5). 
 
 
Table 3 The effect of a single session of Haemodi-
alysis on MDA and TAC 
Parameter Pre-dialysis Post-dialysis p value 
TAC 1232.2 ± 495.6 832.4 ± 325.7 < 0.001 
MDA 11.8 ± 1.8 11.8 ± 2.331 0.753 
 
Table 4 Association between changes in MDA and 
ultrafiltration volume, blood flow rate and blood 
pressure 
 
Table 5 Association between changes in TAC and ultra-
filtration volume, blood flow rate and blood pressure 
 p-value R 
Ultrafiltration volume 0.73 -0.04 
Blood Flow Rate 0.53 -0.11 
Systolic Blood Pressure 0.89 -0.24 
Diastolic Blood Pressure 0.23 0.24 
 
DISCUSSION 
Antioxidants are important in patients with CKD to retard 
disease progression, and reduce the risk of premature de-
velopment of cardiovascular disease (CVD) and death. 
Total antioxidant capacity is a measure of overall body 
defence against free radicals, it is made up of enzymatic 
and non-enzymatic components. 
 
This study showed a significant reduction in the total an-
tioxidant capacity in patients undergoing HD. Oxidative 
stress (OS) has been implicated in the pathogenesis of 
cardiovascular death and CKD patients are at increased 
risk of both OS and cardiovascular death. Incidence of 
cardiovascular events and death has been reported to in-
crease soon after commencement of HD, however the 
mechanism responsible is not fully understood.13 This 
study further suggests that loss of antioxidants across the 
semipermeable dialyzer bio-incompatible membrane 
during the course of HD may play a significant role in 
increased oxidative stress in patients undergoing HD and 
may partly contribute to increased mortality. This study 
is in consonance with observed significant difference in 
the levels of total antioxidants after HD in previous stud-
ies.4,14  
 
Significant imbalance in the amount of pro-oxidants and 
antioxidants have been shown to be prevalent among 
CKD patients, while this has been associated with uremia 
and production of inflammatory cells such as 
polymorphonuclear cells (PMNs), loss of antioxidants 
during dialysis procedure plays a significant role. 
Oxidative stress in HD patients is associated with 
extracorporeal treatments15, repeated contact of blood 
cells with bio-incompatible membrane causing leukocyte 
activation and consequent increased formation of ROS, 
pro-inflammatory cytokine and pro-oxidants.16 The 
inflammatory cells triggers increased secretion of 
myeloperoxidase and nicotinamide adenine dinucleotide 
phosphate oxidase that will also increase the production 
of ROS. Leakage of blood antioxidants through the 
dialysis membrane and higher consumption of 
antioxidant during HD has been described.17 
 
In this study, the levels of plasma MDA, which serves as 
evidence of lipid peroxidation were similar before and 
after HD. Plasma MDA is an intermediate product of 
lipid peroxidation and a marker of oxidative stress. The 
result of our study suggests that HD may not be 
associated with the removal of pro-oxidants molecules 
such as MDA in CKD patients. Though elevated levels 
of MDA has been demonstrated in patients with varying 
degrees of renal functions9,18, this study showed that a 
session of HD did not yield a significant reduction in its 
plasma levels in CKD patients undergoing first session of 
HD. This is in agreement with earlier study19 who 
observed a non-significant difference following HD 
though it’s not stated whether participants were incipient 
or have been on dialysis. In another study by Biasioli et 
al20, post dialysis sample was collected 30 minutes after 
completing HD, MDA values were reported to be similar 
to those pre-dialysis. That study however recruited 
participants who were on regular HD. 
 
In contrast to some studies that observed significant 
increase in lipid peroxidation following HD evidenced by 
elevated MDA level post-dialysis4,17,21, our study did not 
show increased lipid peroxidation rather it did show 
inability of the HD to remove MDA (pro-oxidant 
molecule). The difference may be associated with 
duration of dialysis and method of selection of 
participants. Our study considered incipient dialysis 
patients and a duration of three hours while most other 
studies didn’t state the duration of HD, some studies also 
considered patients on regular maintenance HD.11,21 The 
difference may also be associated with the possibility of 
serum MDA value attaining equilibrium after HD as this 
study sampled post-dialysis 30 minutes after completing 
HD while others collected immediately after HD.  
 
 p-value R 
Ultrafiltration volume 0.73 -0.07 
Blood Flow Rate 0.75 -0.06 
Systolic Blood Pressure 0.50 0.12 
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This is similar to finding in a study that sampled post 
dialysis 30 minutes after completing HD20 suggesting 
that time of collection may be associated with the 
difference.  
 
This study showed that blood flow rate, ultrafiltration 
volume and blood pressure at the onset of dialysis did not 
significantly affect changes in TAC and MDA following 
HD. However, there are no previous reports to compare 
with our findings. 
 
Our study confirmed significant decrease in total 
antioxidant capacity associated with HD that has been 
documented in previous studies and further suggests that 
the possible mechanism may be associated with loss of 
soluble components during HD. Possible cumulative 
effects of this coupled with non-clearance of MDA pose 
dialysis patients at increased risk of oxidative stress. This 
may enhance disease progression, cardiovascular 
complications and increase mortality among these 
patients. However, the use of vitamin E coated dialyzers 
has been suggested to reduce oxidative stress and 
endothelial dysfunction associated with HD.22  
 
CONCLUSION 
This study has further shown that HD is associated with 
significant alteration in antioxidant status of CKD 
patients. Even a single session of HD may contribute to 
OS in CKD patients through loss of antioxidants across 
dialyzer bio incompatible membrane. Clinical trials may 
be necessary to ascertain the probable beneficial effects 




1. Francesco Locatelli , Bernard Canaud , Kai-Uwe 
Eckardt , Peter Stenvinkel , Christoph Wanner and 
Carmine Zoccali. Oxidative stress in end-stage renal 
disease: an emerging threat to patient outcome. 
Nephrol. Dial. Transplant. 2003; 18 (7): 1272-1280. 
2. Fiorillo C, Oliviero C, Rizzuti G, Nediani C, Pacini 
A, Nassi P. Oxidative stress and antioxidant defenses 
in renal patients receiving regular haemodialysis. 
Clin Chem Lab Med. 1998; 36(3):149-53. 
3. Descamps-Latscha B, Drüeke T, Witko-Sarsat V. 
Dialysis-induced oxidative stress: biological 
aspects, clinical consequences, and therapy. Semin 
Dial 2001; 14:193–199 
4. Ajala MO,  Ogunro P.S, Alli Odun. Effect of hemo-
dialysis on total antioxidant status of chronic renal 
failure patients in government hospitals in Lagos Ni-
geria. Niger J Clin Pract 2011:14 (2):154-158. 
5. Witko-Sarsat V, Friedlander M., Capeillère-Blandin 
C., Nguyen-KhoaAnh T., Thu NguyenJohanna, 
ZingraffPaul Jungers, Descamps-Latscha B. Ad-
vanced oxidation protein products as a novel marker 
of oxidative stress in uremia. Kidney International 
May 1996; Vol. 49(5):1304–1313.  
6. Kuo K.-L. and D.-C. Tarng, “Oxidative stress in 
chronic kidney disease”. Adaptive Medicine, 2010; 
2( 2): 87–94,.  
7. Descamps-Latscha B, Goldfarb B, Nguyen AT., 
Kazatchkine M. Establishing the relationship 
between complement activation and stimulation of 
phagocyte oxidative metabolism in hemodialyzed 
patients: a randomized prospective study. Nephron 
1991; 59(2):279–285 
8. Rezaie A, Parker R.D, Abdollahi M. oxidative stress 
and pathogenesis of inflammatory bowel disease: An 
epiphenomenon or the cause? Digestive Diseases 
and Sciences. 2007: 52 (9):2015-2021.  
9. Ong-Ajyooth L, Ong-Ajyooth S, Sirisalee K, 
Nilwarangkur S. Lipoproteins and lipid peroxidation 
abnormalities in patients with chronic renal disease. 
JMedAssoc. Thai. 1996; 79:505–12.  
10. Abefe SA, Abiola AF, Olubunmi AA, Adewale A. 
Utility of predicted creatinine clearance using 
MDRD formula compared with other predictive for-
mulas in Nigerian patients. Saudi J Kidney Dis 
Transpl. 2009; 20:86–90.  
11. Benzie IF, Strain JJ. The ferric reducing ability of 
plasma (FRAP) as a measure of "antioxidant power": 
the FRAP assay. Anal Biochem. 1996; 239(1):70-6.  
12. Varshney R, Kale RF. Effect of Calmodulin 
antagonists on radiation induced lipid peroxidation 
in Microsomes. Int. J. Rad. Biol., 1990; 58: 733- 743. 
13. Bruce  Robinson,  Jinyao  Zhang, Hal Morgenstern, 
Brian D. Bradbury, Leslie J. Ng, Keith  McCullough, 
Brenda  Gillespie, Raymond Hakim, Hugh Rayner, 
Joan  Fort, Tadao Akizawa, Francesca Tentori, and 
Ronald Pisoni. World-wide, mortality is a high risk 
soon after initiation of hemodialysis. Kidney Int. 
2014; 85(1):  158–165. 
14. Kadkhodaee, M., Hemmati, M., Zahmatkesh, M., 
Ghaznavi, R., Mirershadi, F., Mahdavi-Mazde, M. 
and Seifi, B. Assessment of Plasma Antioxidant 
Status in Hemodialysis Patients. Therapeutic 
Apheresis and Dialysis. 2008; 12: 147–151.  
15. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin 
E-bonded hemodialyzer improves atherosclerosis 
associated with a rheo- logical improvement of 
circulating red blood cells. Kidney Int. 2003; 
63(5):1881–1887. 
16. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret 
C, Descamps-Latscha B. Hemodialysis membrane-
induced activation of phagocyte oxidative metabo-
lism detected in vivo and invitro with microamounts 




                                                                                                                                                                               
www.ghanamedj.org  Volume 52 Number 1 March 2018 33 
17. Mehryar Zargari, Omid Sedighi Influence of 
Hemodialysis on Lipid Peroxidation, Enzymatic and 
Non- Enzymatic Antioxidant Capacity in Chronic 
Renal Failure Patients. Nephro Urol 2015; 7(4): 
28526. 
18. Kachhawa K, Varma M, Kachhawa P, Agrawal D, 
Shaikh M, Kumar S. Study of dyslipidemia and an-
tioxidant status in chronic kidney disease patients at 
a hospital in South East Asia. J Health Res Rev 2016; 
(3):28-30. 
19. Lin TH, Chen JG, Liaw JM, Juang JG. Trace ele-
ments and lipid peroxidation in uremic patients on 
hemodialysis. Biol Trace Elem Res. 1996; 
51(3):277- 83. 
20. Biasioli S, Schiavon R, Petrosino L, Cavallini L, 
Cavalcanti G, De Fanti E, Zambello A, Borin D: 
Role of cellulosic and non- cellulosic membranes in 
hyperhomocysteinemia and oxidative stress. ASAIO 
J. 2000; 46: 625-634,. 
21. Ogunro P S, Oluyombo R, Ajala M O, Oshodi T. T. 
The effect of a membrane dialyzer during hemodial-
ysis on the antioxidant status and lipid peroxidation 
of patients with end-stage renal disease. Saudi J Kid-
ney Dis Transpl. 2014; 25:1186-93 
22. Jing Huang, Bin Yi, Ai-mei Li & Hao Zhang. Effects 
of vitamin E-coated dialysis membranes on anemia, 
nutrition and dyslipidemia status in hemodialysis 
patients: a meta-analysis, Renal Failure. 2015;37 
(3): 398-407✪   
 
 
